153 related articles for article (PubMed ID: 35799446)
1. The uptake and utility of genetic testing and genetic counseling for hypertrophic cardiomyopathy-A systematic review and meta-analysis.
Cirino AL; Harris SL; Murad AM; Hansen B; Malinowski J; Natoli JL; Kelly MA; Christian S
J Genet Couns; 2022 Dec; 31(6):1290-1305. PubMed ID: 35799446
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated with Uptake of Genetics Services for Hypertrophic Cardiomyopathy.
Khouzam A; Kwan A; Baxter S; Bernstein JA
J Genet Couns; 2015 Oct; 24(5):797-809. PubMed ID: 25566741
[TBL] [Abstract][Full Text] [Related]
3. The uptake of family screening in hypertrophic cardiomyopathy and an online video intervention to facilitate family communication.
Harris S; Cirino AL; Carr CW; Tafessu HM; Parmar S; Greenberg JO; Szent-Gyorgyi LE; Ghazinouri R; Glowny MG; McNeil K; Kaynor EF; Neumann C; Seidman CE; MacRae CA; Ho CY; Lakdawala NK
Mol Genet Genomic Med; 2019 Nov; 7(11):e940. PubMed ID: 31482667
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy.
van Velzen HG; Schinkel AFL; Baart SJ; Oldenburg RA; Frohn-Mulder IME; van Slegtenhorst MA; Michels M
Circ Genom Precis Med; 2018 Apr; 11(4):e001896. PubMed ID: 29661763
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial Impact of a Positive Gene Result for Asymptomatic Relatives at Risk of Hypertrophic Cardiomyopathy.
Bonner C; Spinks C; Semsarian C; Barratt A; Ingles J; McCaffery K
J Genet Couns; 2018 Sep; 27(5):1040-1048. PubMed ID: 29468337
[TBL] [Abstract][Full Text] [Related]
6. Examining the Psychosocial Impact of Genetic Testing for Cardiomyopathies.
Wynn J; Holland DT; Duong J; Ahimaz P; Chung WK
J Genet Couns; 2018 Aug; 27(4):927-934. PubMed ID: 29243008
[TBL] [Abstract][Full Text] [Related]
7. Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing.
Jensen MK; Havndrup O; Christiansen M; Andersen PS; Diness B; Axelsson A; Skovby F; Køber L; Bundgaard H
Circulation; 2013 Jan; 127(1):48-54. PubMed ID: 23197161
[TBL] [Abstract][Full Text] [Related]
8. Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy.
Christiaans I; Birnie E; Bonsel GJ; Wilde AA; van Langen IM
Eur J Hum Genet; 2008 Oct; 16(10):1201-7. PubMed ID: 18478037
[TBL] [Abstract][Full Text] [Related]
9. Genetic Testing in Hypertrophic Cardiomyopathy.
Ireland CG; Ho CY
Am J Cardiol; 2024 Feb; 212S():S4-S13. PubMed ID: 38368035
[TBL] [Abstract][Full Text] [Related]
10. Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic.
Arad M; Monserrat L; Haron-Khun S; Seidman JG; Seidman CE; Arbustini E; Glikson M; Freimark D
Isr Med Assoc J; 2014 Nov; 16(11):707-13. PubMed ID: 25558701
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation.
van Velzen HG; Schinkel AFL; Oldenburg RA; van Slegtenhorst MA; Frohn-Mulder IME; van der Velden J; Michels M
Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28794111
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy: a systematic review and meta-analysis.
Christian S; Cirino A; Hansen B; Harris S; Murad AM; Natoli JL; Malinowski J; Kelly MA
Open Heart; 2022 Apr; 9(1):. PubMed ID: 35387861
[TBL] [Abstract][Full Text] [Related]
13. Uptake of cardiac screening and genetic testing among hypertrophic and dilated cardiomyopathy families.
Miller EM; Wang Y; Ware SM
J Genet Couns; 2013 Apr; 22(2):258-67. PubMed ID: 23054336
[TBL] [Abstract][Full Text] [Related]
14. Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients' perspective.
Christiaans I; van Langen IM; Birnie E; Bonsel GJ; Wilde AA; Smets EM
Am J Med Genet A; 2009 Jul; 149A(7):1444-51. PubMed ID: 19533783
[TBL] [Abstract][Full Text] [Related]
15. Attitudes, knowledge and consequences of uncertain genetic findings in hypertrophic cardiomyopathy.
Burns C; Yeates L; Spinks C; Semsarian C; Ingles J
Eur J Hum Genet; 2017 Jun; 25(7):809-815. PubMed ID: 28594412
[TBL] [Abstract][Full Text] [Related]
16. Genetic testing and cascade screening in pediatric long QT syndrome and hypertrophic cardiomyopathy.
Knight LM; Miller E; Kovach J; Arscott P; von Alvensleben JC; Bradley D; Valdes SO; Ware SM; Meyers L; Travers CD; Campbell RM; Etheridge SP
Heart Rhythm; 2020 Jan; 17(1):106-112. PubMed ID: 31229680
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing impacts the utility of prospective familial screening in hypertrophic cardiomyopathy through identification of a nonfamilial subgroup.
Ko C; Arscott P; Concannon M; Saberi S; Day SM; Yashar BM; Helms AS
Genet Med; 2018 Jan; 20(1):69-75. PubMed ID: 28640247
[TBL] [Abstract][Full Text] [Related]
18. Genetic Testing and Counseling for Hypertrophic Cardiomyopathy.
Cirino AL; Seidman CE; Ho CY
Cardiol Clin; 2019 Feb; 37(1):35-43. PubMed ID: 30447714
[TBL] [Abstract][Full Text] [Related]
19. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.
Lorenzini M; Norrish G; Field E; Ochoa JP; Cicerchia M; Akhtar MM; Syrris P; Lopes LR; Kaski JP; Elliott PM
J Am Coll Cardiol; 2020 Aug; 76(5):550-559. PubMed ID: 32731933
[TBL] [Abstract][Full Text] [Related]
20. Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.
Frey MK; Ahsan MD; Bergeron H; Lin J; Li X; Fowlkes RK; Narayan P; Nitecki R; Rauh-Hain JA; Moss HA; Baltich Nelson B; Thomas C; Christos PJ; Hamilton JG; Chapman-Davis E; Cantillo E; Holcomb K; Kurian AW; Lipkin S; Offit K; Sharaf RN
J Clin Oncol; 2022 Dec; 40(35):4129-4143. PubMed ID: 35960887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
